Lilly Plant Making Covid Therapy Drug Flagged Again by Inspectors
By Anna Edney, Bloomberg, Oct 20, 2020. U.S. drug-safety inspectors have found continuing quality-control problems at a New Jersey plant Eli Lilly & Co. is using to help produce its Covid-19 antibody therapy, posing a